- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07678723
Pupillary Light Reflex to Predict Post-Spinal Hypotension in Elective Cesarean Delivery
Pupillary Light Reflex for Predicting Hypotension Risk After Spinal Anesthesia for Elective Cesarean Section: A Prospective Observational Cohort Study
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Spinal anesthesia is the standard technique for elective cesarean delivery, yet it is frequently associated with maternal hypotension due to sympathetic blockade. According to the study protocol, spinal anesthesia-induced hypotension (SAIH) occurs in 50-90% of cases, and currently available predictors-including baseline blood pressure, BMI, and block height-demonstrate limited accuracy (AUC <0.65). The pupillary light reflex (PLR) is a sensitive indicator of autonomic nervous system balance, and pupillary reaction latency may reflect parasympathetic conduction efficiency. As noted in the protocol, no published studies have evaluated PLR as a predictor of hypotension after spinal anesthesia in obstetric patients.
This prospective observational cohort study aims to determine whether pre-anesthetic PLR parameters, particularly pupillary reaction latency, can predict the occurrence and severity of hypotension following spinal anesthesia for elective cesarean section. Additional pupillometry parameters-including baseline diameter, constriction velocity, and minimum diameter-will also be assessed. Measurements are obtained using a handheld pupillometer after 5 minutes of dark adaptation, with three readings taken at 60-second intervals.
Following spinal anesthesia with hyperbaric bupivacaine and fentanyl, maternal blood pressure is monitored every 5 minutes for the first 20 minutes. The primary outcome is hypotension, defined as a >20% decrease in systolic blood pressure. Secondary outcomes include severe hypotension, vasopressor requirements, maternal symptoms, and neonatal Apgar scores and umbilical artery pH.
Statistical analysis includes ROC curve evaluation, Youden's index for cutoff determination, and multivariate logistic regression. The study involves no interventions beyond routine care, and pupillometry is non-invasive and safe. Findings may support the development of a novel, objective, and clinically useful predictor for SAIH in obstetric anesthesia.
Studietyp
Inskrivning (Beräknad)
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
Tar emot friska volontärer
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
ASA II Term pregnancy ≥37 weeks Singleton pregnancy Elective cesarean section Age 18-45 years Written informed consent
Exclusion Criteria:
Emergency cesarean section Hypertensive disorders Diabetes mellitus Cardiovascular disease Neurological or autonomic disorders Ophthalmic disease Medications affecting autonomic function BMI >40 kg/m² Failed spinal anesthesia
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Elective Cesarean Section Cohort
Pregnant women (ASA II, term ≥37 weeks) undergoing elective cesarean section under spinal anesthesia.
Participants undergo pre-anesthetic pupillometry and routine perioperative monitoring.
No interventions are administered beyond standard clinical care.
|
This study does not involve any investigational drugs, devices, or therapeutic interventions.
Pupillometry is a non-invasive measurement performed as part of the observational assessment and is not considered an intervention.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Incidence of Hypotension After Spinal Anesthesia
Tidsram: 0-20 minutes after spinal anesthesia
|
Hypotension defined as a >20% decrease in systolic blood pressure from baseline within the first 20 minutes after spinal anesthesia administration.
Blood pressure is measured every 5 minutes as per protocol.
|
0-20 minutes after spinal anesthesia
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Incidence of Severe Hypotension
Tidsram: 0-20 minutes after spinal anesthesia
|
Severe hypotension defined as systolic blood pressure <80 mmHg or requiring vasopressor administration.
|
0-20 minutes after spinal anesthesia
|
|
Total Vasopressor Dose Administered
Tidsram: Intraoperative period (first 20 minutes post-spinal)
|
Total amount of vasopressor medication administered to treat hypotension following spinal anesthesia.
|
Intraoperative period (first 20 minutes post-spinal)
|
|
Maternal Symptoms Associated With Hypotension
Tidsram: Intraoperative period
|
Assessment of maternal symptoms including nausea, vomiting, dizziness, or discomfort associated with hypotension.
|
Intraoperative period
|
|
Neonatal Apgar Scores
Tidsram: 1 minute and 5 minutes postpartum
|
Apgar scores at 1 and 5 minutes after delivery.
|
1 minute and 5 minutes postpartum
|
|
Umbilical Artery pH
Tidsram: Immediately after delivery
|
Measurement of umbilical artery blood pH to assess neonatal acid-base status.
|
Immediately after delivery
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- DFM-IRB 00012367- 26-06-005
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .